Navigation Links
Mayo researchers discover HIV dependence on a human protein

Mayo Clinic virologists have discovered that a specific human protein is essential for HIV to integrate into the human genome. Their findings show that when HIV inserts itself into a chromosome, a key step that enables it to establish a "safe haven," it requires a specific protein -- LEDGF/p75 (p75). This protein forms a molecular tether between chromosomes and HIV's integrating protein (integrase). If the connection can be disrupted in the future, it might lead to new therapy for HIV or safer methods of gene therapy. The details appear today in the journal Science.

"How an incoming virus co-opts the cell's assistance as it proceeds to establish its permanently integrated state is a fascinating question," says Eric Poeschla, M.D., the Mayo Clinic virologist who led the research. "It's critical to understand this better because permanently integrated viruses in long-lived cells prevent elimination of HIV. In the future, it will be of interest to examine whether HIV's dependence on p75 can be exploited therapeutically."

How They Did It

The researchers started by noticing that p75 "tethers" HIV integrase to human chromosomes like a molecular rope and also protects it from the cell's protein-degrading machinery. While these were provocative findings, what they meant for the whole virus was unclear.

The Mayo team then developed a highly effective version of a technique called "RNA interference" to strip all detectable p75 from human chromosomes. Without its p75 partner, HIV was highly impaired. An intriguing irony is their use of a crippled version of HIV itself, a virus with proven skill in accessing the human genome, to deliver the RNA interference. As a result, human T cells, HIV's main target, became resistant to HIV. Adding back p75 made them vulnerable again. And adding a "dominant-negative" piece of p75 to the mix, a sort of molecular spanner in the works, further impaired the virus (over 500-fold).

Moreover, the Mayo
'"/>

Source:Mayo Clinic


Page: 1 2

Related biology news :

1. NYU researchers simulate molecular biological clock
2. Vital step in cellular migration described by UCSD medical researchers
3. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
4. UCSD researchers maintain stem cells without contaminated animal feeder layers
5. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
6. New protein discovered by Hebrew University researchers
7. First real-time view of developing neurons reveals surprises, say Stanford researchers
8. Agilent Technologies releases automated literature search tool for biology researchers
9. Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin
10. Yale researchers identify molecule for detecting parasitic infection in humans
11. US life expectancy about to decline, researchers say

Post Your Comments:
(Date:11/4/2009)..., NEW YORK, Oct. 27 Global Rainmak...y and advanced R&D laboratory, today announced...d is prepared to actively commercialize its suite ...biometric security offerings. ,, During the pas...ns of dollars to develop and deploy a series of co...
(Date:11/3/2009)..., BOCA RATON, FL (November 4, 2009) For more tha...the queen conch ( Strombus gigas ) have been unsuc...oprietary seeding techniques to produce beaded (nu...ueen conch have been developed by scientists from ...graphic Institute (HBOI). With less than two years...
(Date:11/3/2009)...,, WEST LAFAYETTE, Ind. - Chief executives i...d by about 129 times their "ideal salaries" in 200... proposed by a Purdue University researcher to det... pressing economic and corporate governance issues...for CEOs," said Venkat Venkatasubramanian, a profe...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4DuPont Adds Cotton to India Seed Product Lineup 12789 1DuPont Adds Cotton to India Seed Product Lineup 12789 2DuPont Adds Cotton to India Seed Product Lineup 12789 3DuPont Adds Cotton to India Seed Product Lineup 12789 4Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 1Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 2Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 3Wrigley Honored With 2009 Best Employers for Healthy Lifestyles Award 50084 4Nations first childrens hospital based safety store focuses on child injury prevention 50079 1Nations first childrens hospital based safety store focuses on child injury prevention 50079 2
... Researchers from the University of Minnesota Medi...polis VA Medical Center have identified a noninvas...eases. And its as simple as staring at a point of ...essful, painless, and objective diagnosis for brai...iveness of different treatments for these diseases...
... MADISON, WI, AUGUST 22, 2007- Climate change, a r...ns, and Earths surface; however, the study of anot...still very much underground. Few scientists are lo...limate change on groundwater systems. Little is kn...ater are responding to climate change. , Scientis...
... Miami, Fl (Aug 22, 2007) New research shows how ...daptations in order to transfer pollen on differen...lant species to share bats as pollinators. The st...nated flowers of the genus Burmeistera: analysis o...d in this weeks journal Proceedings of the Royal S...
Other Biology News:U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases 2Climate change goes underground 2Climate change goes underground 3How to share a bat 2
(Date:11/6/2009)...ire/ -- Myriant Technologies LLC ("Myriant"), a pr...f renewable bio-chemicals, Uhde Corporation of Am...mbH, one of the world,s leading engineering contra...the engineering, procurement & construction (E...ed on renewable feedstocks. The execution of this...
(Date:11/6/2009)...rstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDA...unced updated results from a Phase II study of int...astatic to the lung in a poster presentation at th...eeting held in Miami Beach, Florida, from November...Phase II Study of Intravenous REOLYSIN (Wild-type ...
(Date:11/5/2009)...ewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ...ird quarter ended September 30, 2009. GenVec repor...or the three months ended September 30, 2009 compa...) in the comparable quarter of 2008. For the nine ... was $14.1 million ($0.15 per share), compared to ...
(Date:11/5/2009)... ThermoGenesis Corp. (Na...oducts for processing and storing adult stem cells...fiscal 2010. ,, For the quarter ended September...illion, a 15 percent increase over revenues of $4....pany said the key contributors to the growth in re...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...c. (Amex:,ADL), developer and marketer of tests fo...diseases, announced today that it has conducted th...S private unit offering of,2,007,508 shares of com...s,of common stock, generating net proceeds of appr...ock were sold at $3.09 per share and the four year...
...,Pharmaceuticals, a division of Wyeth (NYSE: WYE ...ement claim for lost profits and other damages,aga... Teva,s launch of a,pantoprazole tablet -- a gener... disputed that its product infringes the United St... to Wyeth by Altana, recently,acquired by Nycomed,...
...ance in memory storage devices presents a new marv...ry small spaces. Considering the potential of nano... the University of California, Riverside, things a...the latest issue of Technology Review, Khizroev is... point to a future where a 10-terabit hard drive i...
Other Biology Technology:AMDL Announces Closing of Private Offering 2Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent 2Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent 3Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent 4The Library of Congress in your wrist watch? 2
Chicken Anti-Plants Thaumatin 2 Polyclonal Antibody, Unconjugated from Abcam
QCapture Pro Software from QImaging
Anti-XIAP Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-VEGF Receptor 2, phospho (Tyr1214) Polyclonal Antibody, Unconjugated from Abcam
Biology Products: